<DOC>
	<DOC>NCT01766011</DOC>
	<brief_summary>The purpose of this study is to assess overall growth of preterm infants fed a reformulated preterm infant formula during hospitalization. All study products meet levels of nutrients for the infant population as specified in the Infant Formula Act and all subsequent amendments.</brief_summary>
	<brief_title>Evaluation of a Standard Preterm Infant Formula Fed to Preterm Infants in the Hospital</brief_title>
	<detailed_description />
	<criteria>Subjects eligible for study participation will satisfy the following criteria: Birth weight between 1000g 1800g Less than or equal to 34 weeks and 0 days gestational age at birth Appropriate for gestational age (AGA) Singleton or twin births Infant is 21 days of age or less Infants with the following conditions prior to and/or at the time of study product initiation are not eligible for entry into the study: Expected to be transferred to another facility within 14 days Serious congenital abnormalities that may affect growth and development Intubated for ventilation at the time of study product initiation Grade III or IV periventricular/intraventricular hemorrhage (PVH/IVH) Maternal incapacity, maternal drug or alcohol abuse during pregnancy or current abuse, or maternal treatment consistent with human immunodeficiency virus therapy Infant has a history of major surgery Asphyxia defined as progressive hypoxemia and hypercapnia with significant metabolic acidemia Confirmed necrotizing enterocolitis or confirmed sepsis Current use or planned use of probiotics Participation in another study that has not been approved</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Days</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>